Tuesday, October 31, 2023

Roche seeks label expansion for Elevidys amid missing Phase III endpoint

›
  Roche and   Sarepta Therapeutics ’ have announced top-line results from the   Phase III trial   for Elevidys (delandistrogene moxeparvovec...

Banned in Britain: Temu ads 'sexualize kids, objectify women'

›
  The online retailer Temu has had an advert banned for sexualising a child. It showed a girl aged between eight and 11 wearing a bikini in ...

PFAS ‘forever chemicals’ in drinking water can be removed — here’s how

›
  There’s something in the water — and you should get it out. Scientists have sounded the alarm about the group of toxic chemicals commonly ...

Hamas traps 1,000 Americans in Gaza as last US charter plane leaves Israel

›
Roughly 1,000 Americans are stuck in Gaza without a way out as  Hamas terrorists refuse to open the region’s main exit route into Egypt , Se...

How to Defeat Hamas Fast, Cheap and Easy

›
  As the war rages on, Gaza is getting destroyed, people are getting killed on both sides, and a resolution of the conflict seems as elusive...

FDA approves Amgen's biosimilar version of J&J's psoriasis drug

›
  The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoria...

Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured

›
  A multimillion-dollar deal in the healthcare industry announced on Tuesday led to share price pops for two of the three parties involved. ...